Form 4 for BIOA BioAge Labs, Inc.
Accepted 2026-04-24 16:19:14 ET · period of report 2026-04-23 · accession 0001120478-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-24 16:19 | 2026-04-23 | BIOA | GOLDSTEIN DOV A MD | CFO | M - OptEx | $4.38 | +3,542 | 36.6K | +11% | +$15.5K |
| D | 2026-04-24 16:19 | 2026-04-23 | BIOA | GOLDSTEIN DOV A MD | CFO | M - OptEx | $0.00 | -3,542 | 155.8K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-23 | M | A | 3,542 | $4.38 | 36,575 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-04-23 | M | D | 3,542 | $0.00 | 155,833 | D | $4.38 · — to 2035-02-17 | 3,542 Common Stock | (F1) The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. |